Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06128681

Diagnosis and Comprehensive Treatment of Mediastinal Interventional Technique

Application Value of Respiratory Mediastinal Intervention Technique in Diagnosis and Comprehensive Treatment of Diseases

Status
Recruiting
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Dan Liu · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to learn whether patients undergoing mediastinal disease diagnosis and combined treatment with intrapacial ultrasound-guided mediastinal opening techniques have greater clinical benefit. The main questions it aims to answer are: * Whether the mediastinal ultrasound-guided mediastinal opening technique is more beneficial for the diagnosis of benign or malignant mediastinal diseases. * Does the mediastinal ultrasound-guided mediastinal opening technique benefit the patient by ablating mediastinal masses using freezing, laser, or other means. Mediastinal diseases were diagnosed by lymph node biopsy combined with NGS, ROSE and other techniques using transairway ultrasound-guided mediastinal opening technique. Ablation of mediastinal malignancies is performed using techniques such as freezing or laser. Transbronchial lung biopsy(TBLB) may also be performed when necessary. Researchers will compare the experimental group with mediastinal opening and the control group without mediastinal opening to see if Mediastinal open technique benefits patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREIntraairway ultrasound-guided mediastinal opening techniqueMediastinal intervention for patients with mediastinal imaging abnormalities is performed under general anesthesia to obtain biopsy specimens for detection or elimination of mediastinal masses
PROCEDURETransbronchial Lung Biopsy (TBLB)A standardized supplementary procedure performed in all patients with active pulmonary sarcoidosis and fibrosing mediastinitis, regardless of their primary study group assignment, to obtain lung tissue for histopathological diagnosis and disease activity assessment.

Timeline

Start date
2021-12-01
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2023-11-13
Last updated
2026-02-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06128681. Inclusion in this directory is not an endorsement.